Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is...
FDA Device Recall #Z-1130-2015 — Class II — January 26, 2015
Recall Summary
| Recall Number | Z-1130-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 26, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Haemonetics Corporation |
| Location | Braintree, MA |
| Product Type | Devices |
| Quantity | 4,143 kits |
Product Description
Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is a biological control for use with the Thrombelastograph (TEG) Hemostasis System.
Reason for Recall
Specific lots of Level II Control Kits produce high Maximum Amplitude (MA) results, which are outside of the manufacturer's expected Quality Control range for MA parameter.
Distribution Pattern
Worldwide Distribution -- US, Canada, Czech Republic, Denmark, Great Britain, and Sweden.
Lot / Code Information
Lot numbers: HMO 9200 HMO 9217 HMO 9226 HMO 9232 HMO 9276 HMO 9285 HMO 9292 Exp. Date 1/2017
Other Recalls from Haemonetics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1310-2022 | Class II | TEG 5000 Functional Fibrinogen Reagent, Item No... | Apr 26, 2022 |
| Z-1298-2022 | Class II | Product Name: TEG5000 Analyzer (07-022, 07-033)... | Apr 19, 2022 |
| Z-1617-2020 | Class II | TEG Manager software versions used in conjuncti... | Feb 19, 2020 |
| Z-0890-2020 | Class II | CS5/5+ Fastpacks, 225 mL, 20¿ Res Autotransfusi... | Oct 21, 2019 |
| Z-0900-2020 | Class II | JAPAN DISP SET, 261J, 205J, HAR - Product Usage... | Oct 21, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.